227 related articles for article (PubMed ID: 11221993)
1. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
[TBL] [Abstract][Full Text] [Related]
2. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
3. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
Saï P; Rivereau AS
Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
[TBL] [Abstract][Full Text] [Related]
4. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
Maron R; Melican NS; Weiner HL
J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
[TBL] [Abstract][Full Text] [Related]
5. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines.
Polanski M; Melican NS; Zhang J; Weiner HL
J Autoimmun; 1997 Aug; 10(4):339-46. PubMed ID: 9237797
[TBL] [Abstract][Full Text] [Related]
7. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
[TBL] [Abstract][Full Text] [Related]
8. The influence of oral insulin on the development of autoimmune diabetes in NOD mice fed a hypoallergenic diet.
Shehadeh N; Weis R; Teninboum G; Benderly A; Etzioni A; Shamir R
Diabetes Nutr Metab; 2004 Feb; 17(1):1-5. PubMed ID: 15163117
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
Wang H; Li Y; Sun Q; Yang G
Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
[TBL] [Abstract][Full Text] [Related]
11. Oral tolerance: therapeutic implications for autoimmune diseases.
Faria AM; Weiner HL
Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
[TBL] [Abstract][Full Text] [Related]
12. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
[TBL] [Abstract][Full Text] [Related]
13. Insulin in oral immune "tolerance": a one-amino acid change in the B chain makes the difference.
Homann D; Dyrberg T; Petersen J; Oldstone MB; von Herrath MG
J Immunol; 1999 Aug; 163(4):1833-8. PubMed ID: 10438916
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
Jiang TJ; Zhou ZG; Su H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
[TBL] [Abstract][Full Text] [Related]
15. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration.
Hutchings P; Cooke A
J Autoimmun; 1998 Apr; 11(2):127-30. PubMed ID: 9650091
[TBL] [Abstract][Full Text] [Related]
16. Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice.
Urbanek-Ruiz I; Ruiz PJ; Paragas V; Garren H; Steinman L; Fathman CG
Clin Immunol; 2001 Aug; 100(2):164-71. PubMed ID: 11465945
[TBL] [Abstract][Full Text] [Related]
17. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm.
Gong Z; Jin Y; Zhang Y
Vaccine; 2007 Feb; 25(8):1444-51. PubMed ID: 17113687
[TBL] [Abstract][Full Text] [Related]
18. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
19. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
[TBL] [Abstract][Full Text] [Related]
20. Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes.
Devendra D; Paronen J; Moriyama H; Miao D; Eisenbarth GS; Liu E
J Autoimmun; 2004 Aug; 23(1):17-26. PubMed ID: 15236749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
